Shanavas, M <br/><br/>
Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning.  [electronic resource] 

 -  Bone marrow transplantation  Sep 2014 
 - 1162-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2014.131  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Busulfan--administration & dosage<br/>Combined Modality Therapy<br/>Female<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Male<br/>Middle Aged<br/>Primary Myelofibrosis--drug therapy<br/>Retrospective Studies<br/>Survival Analysis<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Vidarabine--administration & dosage<br/>Whole-Body Irradiation--methods